Veracyte, Inc.
VCYT
$30.43
-$0.53-1.71%
| Weiss Ratings | VCYT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Fair | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | C | |||
| Rating Factors | VCYT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Good | |||
| Efficiency Index | Fair | |||
| Solvency Index | Excellent | |||
| Total Return Index | Fair | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | VCYT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 2.07 | |||
| Price History | VCYT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -10.79% | |||
| 30-Day Total Return | -31.53% | |||
| 60-Day Total Return | -31.46% | |||
| 90-Day Total Return | -13.06% | |||
| Year to Date Total Return | -24.75% | |||
| 1-Year Total Return | 37.88% | |||
| 2-Year Total Return | 34.17% | |||
| 3-Year Total Return | 38.70% | |||
| 5-Year Total Return | 43.81% | |||
| 52-Week High % Change | -34.57% | |||
| 52-Week Low % Change | 66.36% | |||
| Price | VCYT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $47.32 | |||
| 52-Week Low Price | $18.61 | |||
| 52-Week Low Price (Date) | Apr 18, 2024 | |||
| 52-Week High Price (Date) | Jan 30, 2025 | |||
| Valuation | VCYT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 2.41B | |||
| Enterprise Value | 2.17B | |||
| Price/Earnings (TTM) | 104.45 | |||
| Earnings Per Share (TTM) | 0.30 | |||
| Earnings Per Share Growth | -128.80% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 5.55 | |||
| Price/Book (Q) | 2.05 | |||
| Enterprise Value/Revenue (TTM) | 4.88 | |||
| Price | $30.43 | |||
| Enterprise Value/EBITDA (TTM) | 42.72 | |||
| Enterprise Value/EBIT | 79.24 | |||
| Market Cap Category | Mid Cap | |||
| Dividends and Shares | VCYT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 79.91M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | VCYT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 650 243 6300 | |||
| Address | 6000 Shoreline Court South San Francisco, CA 94080 | |||
| Website | www.veracyte.com | |||
| Country | United States | |||
| Year Founded | 2006 | |||
| Profitability | VCYT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 6.15% | |||
| Profit Margin | 5.41% | |||
| Management Effectiveness | VCYT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 1.42% | |||
| Return on Equity | 2.17% | |||
| Income Statement | VCYT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 445.76M | |||
| Total Revenue (TTM) | 445.76M | |||
| Revenue Per Share | $5.58 | |||
| Gross Profit (TTM) | 293.73M | |||
| EBITDA (TTM) | 50.90M | |||
| EBIT (TTM) | 27.44M | |||
| Net Income (TTM) | 24.14M | |||
| Net Income Avl. to Common (TTM) | 24.14M | |||
| Total Revenue Growth (Q YOY) | 20.81% | |||
| Earnings Growth (Q YOY) | 118.07% | |||
| EPS Diluted (TTM) | 0.30 | |||
| EPS Diluted Growth (Q YOY) | 115.84% | |||
| Balance Sheet | VCYT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 289.44M | |||
| Cash Per Share (Q) | $3.62 | |||
| Total Current Assets (Q) | 372.27M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 1.18B | |||
| Current Ratio (Q) | 4.734 | |||
| Book Value Per Share (Q) | $15.12 | |||
| Total Assets (Q) | 1.30B | |||
| Total Current Liabilities (Q) | 78.63M | |||
| Total Debt (Q) | 50.74M | |||
| Total Liabilities (Q) | 124.07M | |||
| Total Common Equity (Q) | 1.18B | |||
| Cash Flow | VCYT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -56.28M | |||
| Cash from Financing (TTM) | 4.90M | |||
| Net Change in Cash (TTM) | 23.30M | |||
| Levered Free Cash Flow (TTM) | 66.91M | |||
| Cash from Operations (TTM) | 75.10M | |||
